ArticleCancer management and research2022

First-Line Anlotinib Combined with Stereotactic Body Radiation Therapy for an Octogenarian with Pulmonary Carcinosarcoma.

Long Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.